Jason E. Hill

5.3k total citations · 1 hit paper
54 papers, 3.4k citations indexed

About

Jason E. Hill is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Jason E. Hill has authored 54 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Hematology and 13 papers in Genetics. Recurrent topics in Jason E. Hill's work include Acute Myeloid Leukemia Research (20 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Jason E. Hill is often cited by papers focused on Acute Myeloid Leukemia Research (20 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Jason E. Hill collaborates with scholars based in United States, Japan and United Kingdom. Jason E. Hill's co-authors include Terrie E. Inder, Jeffrey J. Neil, Donna Dierker, David C. Van Essen, John Harwell, Joshua S. Shimony, Christopher D. Smyser, Andrew J. Degnan, Abraham Z. Snyder and Andrei V. Gudkov and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Jason E. Hill

51 papers receiving 3.3k citations

Hit Papers

Longitudinal Analysis of Neural Network Development in Pr... 2010 2026 2015 2020 2010 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Longitudinal Analysis of Neural Network Development in Preterm Infants
    2010 556 citations Christopher D. Smyser, Terrie E. Inder et al. Cerebral Cortex profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason E. Hill United States 24 1.1k 968 715 706 517 54 3.4k
Catherine Lubetzki France 52 2.8k 2.5× 280 0.3× 593 0.8× 828 1.2× 204 0.4× 201 9.8k
Menno van Lookeren Campagne United States 45 2.6k 2.3× 171 0.2× 1.7k 2.3× 359 0.5× 219 0.4× 84 7.4k
Klaus Schmierer United Kingdom 42 908 0.8× 300 0.3× 1.6k 2.3× 1.2k 1.6× 174 0.3× 171 6.9k
Keisuke S. Iwamoto United States 26 989 0.9× 318 0.3× 725 1.0× 1.1k 1.5× 62 0.1× 89 3.5k
Takao Takahashi Japan 33 1.7k 1.5× 224 0.2× 111 0.2× 309 0.4× 432 0.8× 159 4.3k
Jette Lautrup Frederiksen Denmark 48 1.1k 1.0× 169 0.2× 1.4k 2.0× 1.2k 1.6× 86 0.2× 199 8.1k
Joseph Lin United States 27 927 0.8× 397 0.4× 684 1.0× 320 0.5× 51 0.1× 65 3.6k
Anne Schaefer United States 22 1.7k 1.5× 130 0.1× 557 0.8× 183 0.3× 403 0.8× 34 4.3k
Jia Newcombe United Kingdom 56 2.7k 2.4× 140 0.1× 741 1.0× 1.3k 1.8× 109 0.2× 102 9.6k
Bruno Stankoff France 39 1.4k 1.2× 246 0.3× 732 1.0× 495 0.7× 180 0.3× 129 5.8k

Countries citing papers authored by Jason E. Hill

Since Specialization
Citations

This map shows the geographic impact of Jason E. Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason E. Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason E. Hill more than expected).

Fields of papers citing papers by Jason E. Hill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason E. Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason E. Hill. The network helps show where Jason E. Hill may publish in the future.

Co-authorship network of co-authors of Jason E. Hill

This figure shows the co-authorship network connecting the top 25 collaborators of Jason E. Hill. A scholar is included among the top collaborators of Jason E. Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason E. Hill. Jason E. Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malki, Monzr M. Al, Elizabeth Rich, Jason E. Hill, et al.. (2025). Safety, tolerability, and pharmacokinetics of ASP1235 in relapsed or refractory acute myeloid leukemia: A phase 1 study. Leukemia Research. 152. 107690–107690. 2 indexed citations
2.
3.
4.
Miyamoto, Toshihiro, Hee‐Je Kim, Yasushi Hiramatsu, et al.. (2024). A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia. International Journal of Hematology. 121(1). 56–67.
5.
Pratz, Keith W., Mohamad Cherry, Jessica K. Altman, et al.. (2023). Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML. Journal of Clinical Oncology. 41(26). 4236–4246. 27 indexed citations
6.
7.
Smith, Catherine C., Mark J. Levis, Alexander E. Perl, et al.. (2019). Emerging Mutations at Relapse in Patients with FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia Who Received Gilteritinib Therapy in the Phase 3 Admiral Trial. Blood. 134(Supplement_1). 14–14. 17 indexed citations
8.
Wang, Jie, Jing Li, Adisak Tantiworawit, et al.. (2018). A phase III randomized study of gilteritinib versus salvage chemotherapy in FLT3 mutation-positive subjects with relapsed or refractory acute myeloid leukemia. Annals of Oncology. 29. ix92–ix92. 2 indexed citations
9.
Mitra, Sunanda, María Fernández-del-Valle, & Jason E. Hill. (2016). The role of MRI in understanding the underlying mechanisms in obesity associated diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(5). 1115–1131. 13 indexed citations
10.
Shimony, Joshua S., Christopher D. Smyser, Graham Wideman, et al.. (2015). Comparison of cortical folding measures for evaluation of developing human brain. NeuroImage. 125. 780–790. 74 indexed citations
11.
Hill, Jason E., Terrie E. Inder, Jeffrey J. Neil, et al.. (2010). Similar patterns of cortical expansion during human development and evolution. Proceedings of the National Academy of Sciences. 107(29). 13135–13140. 461 indexed citations
12.
Munshi, Neru, Sébastien Jeay, Youzhi Li, et al.. (2010). ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity. Molecular Cancer Therapeutics. 9(6). 1544–1553. 274 indexed citations
13.
Smyser, Christopher D., Terrie E. Inder, Joshua S. Shimony, et al.. (2010). Longitudinal Analysis of Neural Network Development in Preterm Infants. Cerebral Cortex. 20(12). 2852–2862. 556 indexed citations breakdown →
14.
Hill, Jason E., Donna Dierker, Jeffrey J. Neil, et al.. (2010). A Surface-Based Analysis of Hemispheric Asymmetries and Folding of Cerebral Cortex in Term-Born Human Infants. Journal of Neuroscience. 30(6). 2268–2276. 232 indexed citations
15.
Jeay, Sébastien, Neru Munshi, Jason E. Hill, et al.. (2007). ARQ 197, a highly selective small molecule inhibitor of c-Met, with selective antitumor properties in a broad spectrum of human cancer cells. Cancer Research. 67. 2369–2369. 17 indexed citations
16.
Spector, Neil L., Yosef Yarden, Bradley L. Smith, et al.. (2007). Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells. Proceedings of the National Academy of Sciences. 104(25). 10607–10612. 89 indexed citations
17.
Chikamori, Kenichi, Jason E. Hill, Dale Grabowski, et al.. (2006). Downregulation of topoisomerase IIβ in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest. Leukemia. 20(10). 1809–1818. 25 indexed citations
18.
Brandon, Nicholas J., Patrick Delmas, Jason E. Hill, Trevor G. Smart, & Stephen J. Moss. (2001). Constitutive tyrosine phosphorylation of the GABAA receptor γ2 subunit in rat brain. Neuropharmacology. 41(6). 745–752. 49 indexed citations
19.
Zeremski, Marija, Jason E. Hill, Serena S. Kwek, et al.. (1999). Structure and Regulation of the Mouse ing1 Gene. Journal of Biological Chemistry. 274(45). 32172–32181. 59 indexed citations
20.
Adams, R.L.P., Jason E. Hill, Michael J. McGarvey, & A. Rinaldi. (1989). Mouse DNA methylase. Cell Biophysics. 15(1-2). 113–126. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Lubetzki Breakdown of academic impact, for papers by Menno van Lookeren Campagne Breakdown of academic impact, for papers by Klaus Schmierer Breakdown of academic impact, for papers by Keisuke S. Iwamoto Breakdown of academic impact, for papers by Takao Takahashi Breakdown of academic impact, for papers by Jette Lautrup Frederiksen Breakdown of academic impact, for papers by Joseph Lin Breakdown of academic impact, for papers by Anne Schaefer Breakdown of academic impact, for papers by Jia Newcombe Breakdown of academic impact, for papers by Bruno Stankoff
Rankless by CCL
2026